PDCD1LG2 and lung carcinoma: Negative control (NC)-expressing LLC (LLC-NC) and PD-L2-expressing LLC (LLC-PD-L2) cells were intravenously injected into mice to generate lung cancer mouse model, and tumor growth was monitored by micro-CT imaging.